Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
PHPIX vs PJP
Shared holdings
22
PHPIX covered by PJP
27.30%
PJP covered by PHPIX
27.30%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
PHPIX (April 30, 2026)
| Security | Weight | |
|---|---|---|
| US ULTRA BOND CBT Sep25 | 26.33% | |
| ORGANON & CO | 2.71% | |
| CORCEPT THERAPEUTICS INC | 1.80% | |
| ENLIVEN THERAPEUTICS INC | 1.76% | |
| AXSOME THERAPEUTICS INC | 1.70% | |
| OMEROS CORP | 1.60% | |
| PERRIGO CO PLC | 1.58% | |
| DEFINIUM THERAPEUTICS INC | 1.54% | |
| NEKTAR THERAPEUTICS | 1.51% | |
| TREVI THERAPEUTICS INC | 1.51% | |
| TERNS PHARMACEUTICALS INC | 1.48% | |
| INDIVIOR PHARMACEUTICALS INC | 1.46% | |
| PACIRA BIOSCIENCES INC | 1.46% | |
| HARROW INC | 1.43% | |
| JAZZ PHARMACEUTI | 1.43% | |
| HARMONY BIOSCIENCES HOLDINGS INC | 1.42% | |
| ROYALTY PHARMA-A | 1.40% | |
| AMYLYX PHARMACEUTICALS INC | 1.40% | |
| VIATRIS INC | 1.40% | |
| CRINETICS PHARMACEUTICALS INC | 1.37% | |
| ANI PHARMACEUTICALS INC | 1.36% | |
| LIGAND PHARMACEUTICALS | 1.36% | |
| MBX BIOSCIENCES INC | 1.34% | |
| INNOVIVA INC | 1.34% | |
| LIQUIDIA TECHNOLOGIES INC | 1.33% | |
| AMNEAL PHARM INC | 1.32% | |
| XERIS BIOPHARMA HOLDINGS INC | 1.32% | |
| BRISTOL-MYERS SQUIBB CO | 1.32% | |
| EDGEWISE THERAPEUTICS INC | 1.31% | |
| OCULAR THERAPEUTIX INC | 1.29% | |
| PFIZER INC | 1.28% | |
| NUVATION BIO INC | 1.27% | |
| ZOETIS INC CL A | 1.26% | |
| ELANCO ANIMAL HEALTH INC | 1.25% | |
| JOHNSON&JOHNSON | 1.24% | |
| COLLEGIUM PHARMACEUTICAL INC | 1.24% | |
| MERCK & CO | 1.23% | |
| ALUMIS INC | 1.23% | |
| LILLY ELI and CO | 1.21% | |
| TARSUS PHARMACEUTICALS INC | 1.19% | |
| SUPERNUS PHARMACEUTICALS INC | 1.18% | |
| PHIBRO ANIMAL HEALTH CORP CL A | 1.17% | |
| EYEPOINT PHARMACEUTICALS INC | 1.16% | |
| PRESTIGE CONSUMER HEALTHCARE INC | 1.14% | |
| AMPHASTAR PHARMACEUTICALS INC | 1.11% | |
| THERAVANCE B | 1.00% | |
| PHATHOM PHARMACEUTICALS INC | 0.99% | |
| RAPPORT THERAPEUTICS INC | 0.99% | |
| ESPERION THERAPEUTICS INC NEW | 0.97% | |
| CORMEDIX INC | 0.93% |
PJP (Jan. 31, 2026)
| Security | Weight | |
|---|---|---|
| Invesco Private Prime Fund | 5.75% | |
| GILEAD SCIENCES INC | 5.26% | |
| JOHNSON&JOHNSON | 5.12% | |
| MERCK & CO | 5.10% | |
| PFIZER INC | 4.87% | |
| AMGEN INC | 4.75% | |
| ABBVIE INC | 4.51% | |
| LILLY ELI and CO | 4.51% | |
| ABBOTT LABS | 3.99% | |
| LIQUIDIA TECHNOLOGIES INC | 3.65% | |
| VIATRIS INC | 3.19% | |
| BRISTOL-MYERS SQUIBB CO | 2.96% | |
| AMNEAL PHARM INC | 2.90% | |
| PRESTIGE CONSUMER HEALTHCARE INC | 2.89% | |
| PERRIGO CO PLC | 2.88% | |
| SUPERNUS PHARMACEUTICALS INC | 2.74% | |
| HARMONY BIOSCIENCES HOLDINGS INC | 2.66% | |
| BIOGEN INC | 2.62% | |
| ANI PHARMACEUTICALS INC | 2.60% | |
| COLLEGIUM PHARMACEUTICAL INC | 2.59% | |
| AMPHASTAR PHARMACEUTICALS INC | 2.55% | |
| UNITED THERAPEUTICS CORP DEL | 2.53% | |
| REGENERON PHARMACEUTICALS INC | 2.51% | |
| INNOVIVA INC | 2.42% | |
| LIGAND PHARMACEUTICALS | 2.39% | |
| JAZZ PHARMACEUTI | 2.34% | |
| TRAVERE THERAPEUTICS INC | 2.23% | |
| Invesco Private Government Fund | 2.16% | |
| TARSUS PHARMACEUTICALS INC | 2.02% | |
| OCULAR THERAPEUTIX INC | 1.94% | |
| CORCEPT THERAPEUTICS INC | 1.32% | |
| Invesco Government & Agency Portfolio, Institutional Class | 0.03% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.